Adrian Van Bakel

1.6k total citations
10 papers, 446 citations indexed

About

Adrian Van Bakel is a scholar working on Surgery, Transplantation and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Adrian Van Bakel has authored 10 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 6 papers in Transplantation and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Adrian Van Bakel's work include Transplantation: Methods and Outcomes (7 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Organ Transplantation Techniques and Outcomes (3 papers). Adrian Van Bakel is often cited by papers focused on Transplantation: Methods and Outcomes (7 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Organ Transplantation Techniques and Outcomes (3 papers). Adrian Van Bakel collaborates with scholars based in United States, Canada and Germany. Adrian Van Bakel's co-authors include Howard J. Eisen, Robert L. Kormos, Randall C. Starling, Richard D. Mamelok, Ray E. Hershberger, Robert B. Love, Robert D. Gordon, Jon Kobashigawa, Heather J. Ross and C. Cornu-Artis and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and American Journal of Transplantation.

In The Last Decade

Adrian Van Bakel

8 papers receiving 429 citations

Peers

Adrian Van Bakel
Hunt Sa United States
O'Connell Jb United States
Starnes Va United States
Pauline Whitmore United Kingdom
A. Heroux United States
W. Austin Davis United States
Erwin de Vries Netherlands
Joel D. Cooper United States
K. Raza United States
Hunt Sa United States
Adrian Van Bakel
Citations per year, relative to Adrian Van Bakel Adrian Van Bakel (= 1×) peers Hunt Sa

Countries citing papers authored by Adrian Van Bakel

Since Specialization
Citations

This map shows the geographic impact of Adrian Van Bakel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Van Bakel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Van Bakel more than expected).

Fields of papers citing papers by Adrian Van Bakel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian Van Bakel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Van Bakel. The network helps show where Adrian Van Bakel may publish in the future.

Co-authorship network of co-authors of Adrian Van Bakel

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian Van Bakel. A scholar is included among the top collaborators of Adrian Van Bakel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian Van Bakel. Adrian Van Bakel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Khush, Kiran K., Shelley Hall, Andrew Kao, et al.. (2024). Surveillance with dual noninvasive testing for acute cellular rejection after heart transplantation: Outcomes from the Surveillance HeartCare Outcomes Registry. The Journal of Heart and Lung Transplantation. 43(9). 1409–1421. 12 indexed citations
2.
Waring, Ashley, Bhavadharini Ramu, Adrian Van Bakel, et al.. (2023). Need for cardiac implantable electronic devices and long-term follow-up in recipients of orthotopic heart transplants. Heart Rhythm. 21(2). 153–160.
3.
Acharya, Prakash, et al.. (2022). Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine. Journal of Cardiac Failure. 28(12). 1683–1691. 8 indexed citations
4.
Kobashigawa, Jon, Kiran K. Khush, Monica Colvin, et al.. (2017). Report From the American Society of Transplantation Conference on Donor Heart Selection in Adult Cardiac Transplantation in the United States. American Journal of Transplantation. 17(10). 2559–2566. 85 indexed citations
5.
Eisen, Howard J., Jon Kobashigawa, R.C. Starling, et al.. (2013). Everolimus Versus Mycophenolate Mofetil in Heart Transplantation: A Randomized, Multicenter Trial. American Journal of Transplantation. 13(5). 1203–1216. 162 indexed citations
6.
Ghali, Jalal K., Ron M. Oren, Stephanie H. Dunlap, et al.. (2012). BETA-1 ADRENERGIC RECEPTOR GENOTYPE SER49GLY IS ASSOCIATED WITH BETA-BLOCKER SURVIVAL BENEFIT IN PATIENTS WITH HEART FAILURE. Journal of the American College of Cardiology. 59(13). E861–E861. 6 indexed citations
7.
Kobashigawa, Jon, Daniel Pauly, Heather J. Ross, et al.. (2012). 201 Multicenter Randomized Trial of Everolimus vs. Mycophenolate Mofetil in Heart Transplantation: Final 24 Month Analysis of Efficacy and Safety. The Journal of Heart and Lung Transplantation. 31(4). S75–S75. 2 indexed citations
8.
Eisen, Howard J., Daniel Pauly, H. Lehmkuhl, et al.. (2011). 55 Everolimus with Reduced CsA vs MMF with Standard CsA Exposure in De Novo Heart Transplant Recipients: 12 Month Efficacy and Safety Analysis. The Journal of Heart and Lung Transplantation. 30(4). S25–S26.
9.
White‐Williams, Connie, et al.. (2006). Improving Clinical Practice: Should We Give Influenza Vaccinations to Heart Transplant Patients?. The Journal of Heart and Lung Transplantation. 25(3). 320–323. 31 indexed citations
10.
Hershberger, Ray E., Randall C. Starling, Howard J. Eisen, et al.. (2005). Daclizumab to Prevent Rejection after Cardiac Transplantation. New England Journal of Medicine. 352(26). 2705–2713. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026